
































































Association of diabetes with atrial fibrillation types: Protocol for a systematic 
review and meta-analysis 
 
Review question 
Our systematic review aims to summarize the evidence regarding the association of diabetes 
with AF types, in humans. In order to provide insights concerning the role of diabetes on the 
pathophysiology of AF, we will also perform a meta-analysis on the association of diabetes 
with the likelihood of having non-paroxysmal AF rather than paroxysmal AF.  
 
Searches 
An expert medical librarian will perform the search on the following bibliographic electronic 
databases: Embase, Medline Ovid, Cochrane Central, Web of Science Core Collection, and 
Google Scholar. There will be no language or date restrictions. 
 
Types of study to be included 
Inclusion criteria 
(i) Studies in humans 
(ii) Observational studies, including cross-sectional studies, prospective studies, case-control 
studies, nested case-control, nested case-cohort studies 
(iii) Studies that investigated the association of diabetes with the likelihood of having a 
certain AF type rather than another AF type 
(iv) Studies providing information on effect estimates (risk ratio, hazard ratio [HR], odds ratio 
[OR]) with 95% confidence intervals [95% CI] or p-values 
(v) No restrictions on publication year or language. 
Exclusion criteria 
Animal studies, reviews, meta-analyses, conference abstracts, conference proceedings, 
poster presentations, case-series, and letters to editor. 
 
Condition or domain being studied 
Diabetes mellitus, atrial fibrillation, atrial fibrillation types, including paroxysmal, persistent, 
long-standing persistent, permanent AF. 
 
Participants/population 









Atrial fibrillation types   
 
Data extraction (selection and coding) 
This systematic review will be conducted following a recently published guide on how to 
perform a systematic review and meta-analysis; and will be reported following the the 
Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 
recommendations. Two reviewers will independently screen the selected citations by title and 
abstract. Furthermore, the reviewers will independently evaluate the full texts of relevant 
articles. In case of disagreement between the reviewers regarding inclusion, a decision will be 
made by consensus or a third reviewer will be consulted. The reference list of included articles 
will be hand searched to identify additional studies. A predesigned data collection form will be 
used to extract relevant information from the selected studies, including first author`s last 
name, year of publication, country where the study was conducted, study population, number 
of participants at baseline, mean age, percentage of women, diabetes assessment, 
adjustments for potential confounders, outcome, follow-up time, and risk estimates with 95% 
CI.  
 
Risk of bias (quality) assessment 
The quality of the included studies will be assessed separately by two reviewers using the 
Newcastle–Ottawa Scale (NOS) for non-randomized studies. The NOS scale evaluates the 
study quality based on 3 domains, namely selection of participants, comparability of study 
groups, and ascertainment of the outcomes of interest, with a maximum of nine stars for 
every study assessed.  
  
Strategy for data synthesis 
We will provide a narrrative synthesis of the findings of eligible studies. The studies classifying 
AF types into paroxysmal (reference) and non-paroxysmal will be included in the meta-
analysis, if applicable. The effect estimates on the association of diabetes with the likelihood 
of non-paroxysmal AF (vs paroxysmal AF) will be pooled, using random effects models as 
described by DerSimonian and Laird. Forest plots will be constructed. Heterogeneity will be 
assessed by using the I² statistic, with I² ≤ 25% considered as low, 25 %  <  I² < 75% as 
moderate, and I² ≥75% as high. If applicable, we will use funnel plots and Egger regression 
symmetry tests to evaluate the possibility of publication bias. Statistical analyses will be 
performed using Stata IC version 15.1 (StataCorp LLC, Texas, USA) 
 
Analysis of subgroups or subsets 
Sensitivity analyses will be performed whenever appropriate. To evaluate the role of 
individual studies on the overall results, we will recalculate the estimates after removing the 
studies one by one from the pooled analysis. Moreover, we will restrict the analysis to 
studies that define AF types in accordance with the guidelines. 
 
Contact details for further information  
Arjola Bano arjola.bano@ispm.unibe.ch 
 
Organisational affiliation of the review 
Institute of Social and Preventive Medicine, University of Bern 
www.ispm.unibe.ch 
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Type and method of review 
Systematic review, meta-analysis 
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Stage of review  
Ongoing  
 
Subject index terms  
Diabetes mellitus; atrial fibrillation; paroxysmal, non-paroxysmal, persistent, permanent. 
 
